Cargando…
Pancreatic Cancer: BRCA Targeted Therapy and Beyond
SIMPLE SUMMARY: Pancreatic cancer is associated with poor outcomes for several reasons, including diagnosis at an advanced stage, the absence of effective screening for the diagnosis, and resistance to treatments. Pancreatic cancers associated with BRCA1/2 mutations have emerged as a distinct subgro...
Autores principales: | Keane, Fergus, O’Connor, Catherine A., Park, Wungki, Seufferlein, Thomas, O’Reilly, Eileen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251879/ https://www.ncbi.nlm.nih.gov/pubmed/37296917 http://dx.doi.org/10.3390/cancers15112955 |
Ejemplares similares
-
Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge
por: Keane, Fergus, et al.
Publicado: (2023) -
Pancreatic Cancer: Beyond Brca Mutations
por: Ricci, Vincenzo, et al.
Publicado: (2022) -
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
por: Zheng-Lin, Binbin, et al.
Publicado: (2022) -
Duration of therapy for locally advanced pancreatic cancer: Does it matter?
por: Tuli, Richard, et al.
Publicado: (2020) -
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer
por: Golan, Talia, et al.
Publicado: (2017)